18F-LN1 PET/CT in Urothelial Carcinomas
Recruiting
- Conditions
- Urothelial Carcinoma
- Registration Number
- NCT06120413
- Lead Sponsor
- Sichuan Provincial People's Hospital
- Brief Summary
The clinical feasibility of 18F-LN1 PET/CT will be evaluated in 30 patients with urothelial carcinoma, and the results will be compared with those of 18F-FDG.
- Detailed Description
This study aims to evaluate the recognition efficiency of 18F-LN1 and 18F-FDG PET imaging for tumor target Nectin-4 in patients with urothelial carcinoma. The main method is to compare the results of visually interpreted PET images with histopathological results (through surgery or biopsy), which are the gold standard for final diagnosis.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Age 18 and above
- No gender difference
- Patients who have been diagnosed with, or are clinically highly suspected of, urothelial carcinomas and have had no other treatment within 3 months
Exclusion Criteria
- Hypertension that is difficult to control with medication, and systolic blood pressure exceeding 160mmHg
- Complicated with chronic liver disease, myocardial infarction, stroke
- Female patients who are pregnant (or attempting to become pregnant within six months), breastfeeding, or unwilling to use contraception
- Abnormal cardiopulmonary function or mental state, unable to tolerate prone lying for 20 minutes
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of 18F-LN1 and 18F-FDG Uptake in Patients with urothelial carcinoma 1 mouth The correlation between the results of PET images and histopathological results
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Departments of Nuclear Medicine, Sichuan Provincial People's Hospital
🇨🇳Chengdu, Sichuan, China